Annual report pursuant to Section 13 and 15(d)

Stockholders' (Deficiency) Equity - Restricted Stock Units and Performance Restricted Stock Units - Activity (Details)

v3.24.1.1.u2
Stockholders' (Deficiency) Equity - Restricted Stock Units and Performance Restricted Stock Units - Activity (Details) - $ / shares
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Shares    
Nonvested, balance at the beginning of the period (in shares) 497,281  
Granted (in shares) 328,963  
Vested and issued (in shares) (194,444)  
Forfeited (in shares) (39,995)  
Nonvested, balance at the end of the period (in shares) 591,805 497,281
Awards expected to vest (in shares) 591,805  
Weighted Average Grant-Date Fair Value    
Nonvested restricted stock units outstanding at the beginning of the period (in dollars per share) $ 5.65  
Granted (in dollars per share) 5.40  
Vested and issued (in dollars per share) 5.18  
Forfeited (in dollars per share) 5.78  
Nonvested restricted stock units outstanding at the end of the period (in dollars per share) 5.66 $ 5.65
Awards expected to vest (in dollars per share) 5.66  
Restricted stock units    
Weighted Average Grant-Date Fair Value    
Granted (in dollars per share) $ 5.40 $ 5.28